Company news

Certara, Inc. news in 2024

Certara, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Certara Showcases 2024 Research Wins With Over 100 Papers Published

December 1, 2024

Certara Reports Third Quarter 2024 Financial Results

November 5, 2024

Certara to Participate in the Stephens Annual Investment Conference

October 27, 2024

Certara Appoints John Reynders as New Independent Board Member

October 15, 2024

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

October 8, 2024

Certara Completes Acquisition of Chemaxon

October 1, 2024

Certara’s Simcyp Consortium Celebrates 25th Anniversary

September 23, 2024

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

September 17, 2024

Certara Launches Phoenix™ Version 8.5 Drug Development Software

August 14, 2024

Certara Reports Second Quarter 2024 Financial Results

August 5, 2024

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

July 8, 2024

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

July 1, 2024

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

June 16, 2024

Certara to Participate in the Jefferies Global Healthcare Conference

May 28, 2024

Certara Appoints New Chief Human Resources Officer & General Counsel

May 20, 2024

Certara Reports First Quarter 2024 Financial Results

May 6, 2024

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

April 15, 2024

Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference

April 8, 2024

Certara Reports Fourth Quarter 2023 Financial Results

February 28, 2024

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

January 31, 2024

Calls in 2024

Decks in 2024